Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Summary

This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.

Timeline

Start

2022-03-03

Primary completion

2028-10-12

Completion

2032-09-30

Drugs

Indications